|
COMMERCE BUSINESS DAILY ISSUE OF JANUARY 20,1995 PSA#1266U.S. ARMY MED. RESEARCH ACQUISITION ACT, MCMR-RMA-RC, FORT DETRICK
BLDG. 820, FREDERICK MD 21702-5014 A -- SOURCES SOUGHT SOL DAMD17-CBD5-0007 DUE 033195 POC Patricia M.
McAllister, Contracting Officer, (301) 619-7360 The U.S. Army Medical
Research and Materiel Command is currently seeking basic research
proposals to develop an immunoassay for quantitating thiodiglycol
(2,2'-thiodiethanol) in urine and other biological fluids. The
immunoassay should demonstrate the specificity and sensitivity
necessary to be used as a screen for thiodiglycol in urine samples and
biological fluids. Also the immunoassay method should be simple and
portable for use in the field. The offerer is expected to have
expertise in monoclonal antibody technology. In addition, the offerer's
facility should be currently fully operational for such work. While the
offerer chosen for award of any contract is not limited to use
Government supplied haptens to aid in the development of a monoclonal
antibody for thiodiglycol, the offerer may obtain from the Government
four haptens to use in preparing test antigens and immunizing antigens.
Available Government supplied haptens are: (a) Set 1.
4-(2-hydroxyethyl) benzoic acid for the preparation of an immunizing
antigen and 8-hydroxyoctanoic acid for the preparation of the test
antigen, and (b) Set 2. 4-(2-hydroxyethylthio) benzoic acid for the
preparation of an immunizing antigen and 6-(2-hydroxyethylthio)
hexanoic acid for the preparation of the test antigen. Following both
contractor and Army characterization of the monoclonal antibodies
produced by the offerer, the offerer will produce 500 milligrams of the
monoclonal antibody selected by the Army. All cell lines developed
during the investigation will become the property of the Army following
completion of the project. Proposers are encouraged to survey the open
literature on this topic prior to submitting their research ideas in
a preproposal for Army review. This research will support a program on
medical countermeasures against vesicating chemical warfare agents.
This acquisition is reserved for exclusive participation by
Historically Black College/Universities (HBCU), Minority Institutions
(MI) and Small and Disadvantaged Businesses (SDB). Proposals may be
submitted during the period 1 October 1994 through 31 March 1995.
Proposals received under the set-aside will be reviewed and evaluated
separately from other research proposals. If no acceptable proposals
are received under these set- asides during these time periods, these
areas will then become unrestricted and proposals may be submitted by
any interested party. Write to the Contracting Officer in number 7.
above for instructions regarding submission of preproposals under the
Broad Agency Announcement. (0018) Loren Data Corp. http://www.ld.com (SYN# 0018 19950119\A-0018.SOL)
A - Research and Development Index Page
|
|